Literature DB >> 27587722

Invited Commentary: Beware the Test-Negative Design.

Daniel Westreich, Michael G Hudgens.   

Abstract

In this issue of the Journal, Sullivan et al. (Am J Epidemiol. 2016;184(5):345-353) carefully examine the theoretical justification for use of the test-negative design, a common observational study design, in assessing the effectiveness of influenza vaccination. Using modern causal inference methods (in particular, directed acyclic graphs), they describe different threats to the validity of inferences drawn about the effect of vaccination from test-negative design studies. These threats include confounding, selection bias, and measurement error in either the exposure or the outcome. While confounding and measurement error are common in observational studies, the potential for selection bias inherent in the test-negative design brings into question the validity of inferences drawn from such studies.
© The Author 2016. Published by Oxford University Press on behalf of the Johns Hopkins Bloomberg School of Public Health. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Keywords:  confounding; epidemiologic methods; influenza vaccine; selection bias; test-negative study design

Mesh:

Year:  2016        PMID: 27587722      PMCID: PMC5013886          DOI: 10.1093/aje/kww063

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  6 in total

1.  Inverse probability weighted estimation of the marginal odds ratio: correspondence regarding 'The performance of different propensity score methods for estimating marginal odds ratios'.

Authors:  Andrew Forbes; Susan Shortreed
Journal:  Stat Med       Date:  2008-11-20       Impact factor: 2.373

2.  Comments on 'The performance of different propensity score methods for estimating marginal odds ratios'.

Authors:  Erika Graf; Martin Schumacher
Journal:  Stat Med       Date:  2008-08-30       Impact factor: 2.373

3.  Estimators and confidence intervals for the marginal odds ratio using logistic regression and propensity score stratification.

Authors:  Susanne Stampf; Erika Graf; Claudia Schmoor; Martin Schumacher
Journal:  Stat Med       Date:  2010-03-30       Impact factor: 2.373

4.  A comparison of marginal odds ratio estimators.

Authors:  Travis M Loux; Christiana Drake; Julie Smith-Gagen
Journal:  Stat Methods Med Res       Date:  2016-09-30       Impact factor: 3.021

5.  Theoretical Basis of the Test-Negative Study Design for Assessment of Influenza Vaccine Effectiveness.

Authors:  Sheena G Sullivan; Eric J Tchetgen Tchetgen; Benjamin J Cowling
Journal:  Am J Epidemiol       Date:  2016-09-01       Impact factor: 4.897

6.  The test-negative design for estimating influenza vaccine effectiveness.

Authors:  Michael L Jackson; Jennifer C Nelson
Journal:  Vaccine       Date:  2013-03-13       Impact factor: 3.641

  6 in total
  13 in total

1.  THE AUTHORS REPLY.

Authors:  Daniel Westreich; Michael G Hudgens
Journal:  Am J Epidemiol       Date:  2017-04-01       Impact factor: 4.897

2.  Measurement of Vaccine Direct Effects Under the Test-Negative Design.

Authors:  Joseph A Lewnard; Christine Tedijanto; Benjamin J Cowling; Marc Lipsitch
Journal:  Am J Epidemiol       Date:  2018-12-01       Impact factor: 4.897

3.  Uses of pathogen detection data to estimate vaccine direct effects in case-control studies.

Authors:  Joseph A Lewnard
Journal:  J R Soc Interface       Date:  2020-08-12       Impact factor: 4.118

4.  Temporal Confounding in the Test-Negative Design.

Authors:  Natalie E Dean; M Elizabeth Halloran; Ira M Longini
Journal:  Am J Epidemiol       Date:  2020-11-02       Impact factor: 4.897

5.  Analysis of counts for cluster randomized trials: Negative controls and test-negative designs.

Authors:  Suzanne M Dufault; Nicholas P Jewell
Journal:  Stat Med       Date:  2020-01-30       Impact factor: 2.373

6.  Effectiveness of the BNT162b2 (Pfizer-BioNTech) and the ChAdOx1 nCoV-19 (Oxford-AstraZeneca) vaccines for reducing susceptibility to infection with the Delta variant (B.1.617.2) of SARS-CoV-2.

Authors:  Karan Pattni; Daniel Hungerford; Sarah Adams; Iain Buchan; Christopher P Cheyne; Marta García-Fiñana; Ian Hall; David M Hughes; Christopher E Overton; Xingna Zhang; Kieran J Sharkey
Journal:  BMC Infect Dis       Date:  2022-03-20       Impact factor: 3.090

7.  Immune correlates analysis using vaccinees from test negative designs.

Authors:  Dean A Follmann; Lori Dodd
Journal:  Biostatistics       Date:  2022-04-13       Impact factor: 5.279

8.  Estimating population effects of vaccination using large, routinely collected data.

Authors:  M Elizabeth Halloran; Michael G Hudgens
Journal:  Stat Med       Date:  2017-07-19       Impact factor: 2.373

9.  Cluster-Randomized Test-Negative Design Trials: A Novel and Efficient Method to Assess the Efficacy of Community-Level Dengue Interventions.

Authors:  Katherine L Anders; Zoe Cutcher; Immo Kleinschmidt; Christl A Donnelly; Neil M Ferguson; Citra Indriani; Peter A Ryan; Scott L O'Neill; Nicholas P Jewell; Cameron P Simmons
Journal:  Am J Epidemiol       Date:  2018-09-01       Impact factor: 4.897

10.  Decreased effectiveness of the influenza A(H1N1)pdm09 strain in live attenuated influenza vaccines: an observational bias or a technical challenge?

Authors:  Pasi M Penttinen; Martin H Friede
Journal:  Euro Surveill       Date:  2016-09-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.